Francesco Gagliardotto

Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Aurelio Maggio, Angela Vitrano, Marcello Capra et al. · Blood Cells Molecules and Diseases · 2009 · 96 citations

Hematology, Clinical Trials, Italian Society +5

Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel

V. Di Marco, Marcello Capra, Emanuele Angelucci et al. · Blood · 2010 · 94 citations · Full text

Long‐term sequential deferiprone–deferoxamine <i>versus</i> deferiprone alone for thalassaemia major patients: a randomized clinical trial

Aurelio Maggio, Angela Vitrano, Marcello Capra et al. · British Journal of Haematology · 2009 · 69 citations

Drug Safety, Therapeutic Drug Monitoring, Randomized Clinical Trial +11

The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major‐intermedia dichotomy?

Angela Vitrano, Giuseppina Calvaruso, Eliana Lai et al. · British Journal of Haematology · 2016 · 56 citations · Full text

Heart Failure, Iron Metabolism, Prognosis +19

Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) – lack of interference by iron deposition

V. Di Marco, F. Bronte, Daniela Cabibi et al. · British Journal of Haematology · 2009 · 55 citations

Liver Fibrosis, Liver Iron Concentration, Iron Metabolism +21